Kristi R Sims

Title: Innovations by Kristi R Sims in Intranasal Drug Delivery

Introduction

Kristi R Sims is an accomplished inventor based in Versailles, KY (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of drug products for intranasal administration. With a total of 2 patents, her work focuses on improving the delivery of opioid receptor antagonists.

Latest Patents

Kristi's latest patents include innovative drug products designed for nasal delivery. One of her notable inventions provides a pharmaceutical composition that includes naloxone hydrochloride, glycerin, a citrate buffer system, and purified water. This formulation is specifically designed to treat opioid overdoses by allowing for effective intranasal administration. The aqueous pharmaceutical solution is carefully balanced to maintain a pH between 3.5 and 4.7, ensuring optimal delivery and efficacy.

Career Highlights

Kristi R Sims is currently associated with Summit Biosciences Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating effective solutions for urgent medical needs, particularly in the context of opioid overdose treatment.

Collaborations

Throughout her career, Kristi has collaborated with notable colleagues, including Gregory G Plucinski and Adrian T Raiche. These partnerships have fostered a collaborative environment that enhances innovation and the development of new pharmaceutical solutions.

Conclusion

Kristi R Sims exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to intranasal drug delivery are paving the way for more effective treatments for opioid overdoses. Her work not only highlights her expertise but also underscores the importance of collaboration in advancing medical science.